Results 171 to 180 of about 19,654 (289)

Oncological Outcomes of Salvage Oropharyngectomy in Irradiated Neck for Recurrent or Metachronous Squamous Cell Carcinoma

open access: yesHead &Neck, Volume 48, Issue 6, Page 1668-1676, June 2026.
ABSTRACT Objective To evaluate oncological outcomes and their predictors following salvage oropharyngectomy. Methods This single‐center retrospective study included patients who underwent a salvage oropharyngectomy in an irradiated neck for recurrent or metachronous oropharyngeal squamous cell carcinoma (OPSCC) between 2014 and 2023.
Jade Saykaly   +8 more
wiley   +1 more source

Functional Endoscopic Sinus Surgery and Recurrence of Post-COVID Mucormycosis. [PDF]

open access: yesJ Maxillofac Oral Surg, 2022
Rudagi BM, Goyal J, Palande C, Patil P.
europepmc   +1 more source

Mesna in Otologic Surgery: Efficacy and Safety—A Scoping Review

open access: yesThe Laryngoscope, Volume 136, Issue 6, Page 2449-2460, June 2026.
PRISMA flow diagram indicating the process of systematic inclusion and exclusion of articles. ABSTRACT Objective Mesna (Sodium 2‐mercaptoethanesulfonate) is widely used as a mucolytic agent and uroprotective agent. Recently, its disulfide bond‐breaking property has been applied in otologic surgery to facilitate safer dissection of cholesteatoma and ...
Kevork H. Atamian   +4 more
wiley   +1 more source

Choice and Death: Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario

open access: yesThe Laryngoscope, Volume 136, Issue 6, Page 2598-2604, June 2026.
The uptake of MAiD for head and neck cancer (HNC) has been steadily increasing since 2016, when MAiD first became available in Canada. Our study projects a substantial increase in the future use of MAiD for patients with HNC. As such, our health system needs to re‐evaluate and implement the necessary infrastructure to support the projected increase in ...
Tanika Curry   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy